elisanicolini

79 posts

elisanicolini

elisanicolini

@elinico5

Scienza Moda & Design Notizie Lifestyle

Ancona, Marche Katılım Ekim 2018
94 Takip Edilen58 Takipçiler
elisanicolini retweetledi
Raffaele Piccolo
Raffaele Piccolo@piccoloraf·
Very important data from PARTNER-3 presented at #TCT2025 👇 At 7 years, the composite endpoint (death, MI, stroke, or rehospitalization) occurred in 34.6% with TAVR vs 37.2% with surgery (difference -2.6%; 95% CI, -9.0 to 3.7). No differences between the two groups in stroke, myocardial infarction, valve deterioration, endocarditis, and revascularization. Perhaps the most informative figure ⬇️: the vital status sweep analysis. After accounting for patients initially lost to follow-up but later confirmed dead, the apparent late excess mortality with TAVR disappeared, highlighting the critical value of complete follow-up ascertainment. Overall, TAVR remains a very safe and effective option for low-risk patients with aortic stenosis at long-term follow-up. @djc795 @PhilGenereuxMD @mirvatalasnag @PPibarot @tavrkapadia @kaulcsmc @Hragy @sbrugaletta @g_giustinoMD @SVRaoMD @DLBHATTMD @azeemlatib @DrPascalMeier @aakriti_15 @SripalBangalore @nadig_cardio @aymanka @drptca @drpkhazracardi1 @TCTMD @aayshacader @PedroMDMSc @Ortega_Paz @ThomPilgrim @DFCapodanno @PCRonline @HadyLichaaMD
Raffaele Piccolo tweet media
NEJM@NEJM

Presented at #TCT2025: In low-risk patients with severe aortic stenosis, transcatheter and surgical aortic-valve replacement had similar 7-year survival and valve durability outcomes, with no evidence of differences in composite end points. Full PARTNER 3 trial results: nej.md/4nieHfx @CRFHeart

English
0
9
34
6.5K
elisanicolini retweetledi
Agnes Koczo
Agnes Koczo@AkoczoAgnes·
📣Excited to share our new publication in @JACCJournals #JACCAdvances "Beyond Parental Leave: Addressing Infertility, Pregnancy, and Postpartum Complications Among Cardiologists" Thanks to #ACCWIC @gina_lundberg for allowing us platform to discuss these issues at #ACC2024
Agnes Koczo tweet media
English
2
16
39
3.3K
elisanicolini
elisanicolini@elinico5·
@necipermis2 @CerrahpasaC Ivus-guided pci with minimum dose of contrast will not change kidney function and could be a better option than cabg especially if venous graft was used instead of arterial graft.
English
1
0
1
0
necipermis
necipermis@necipermis2·
@CerrahpasaC The patient is very young, percutaneus revascularization will likely result in kidney damage. CABG seems like a good solution
English
1
0
1
0
Cerrahpasa cardiology
Cerrahpasa cardiology@CerrahpasaC·
ACS patient CABG vs PCI? Features that effect outcomes but not included in the gidelines which you should keep in mind while deciding CRF, creatinin 2.6 mg/dl, no routine dialysis Previous non-disabling ischemic stroke 52 years old LVEF 45 and moderate mitral regurgitation
English
11
2
26
0
Francesco Saia
Francesco Saia@saia_francesco·
Very sad and unbelievable news today for our community. Great gentleman, elegant, kind, nice, excellent interventional Cardiologist and scientist. Ciao Michele RIP @sicigise @EAPCIPresident @PCRonline
Francesco Saia tweet media
English
43
33
240
0
Gregg W. Stone MD
Gregg W. Stone MD@GreggWStone·
Our perspective on the vulnerable plaque and vulnerable patient just published in Nature Reviews Cardiology. Please DM me a request with your email address and I would be pleased to send you a journal-approved copy.
Gregg W. Stone MD tweet media
English
134
93
464
0
elisanicolini retweetledi
FRANCESCO BURZOTTA
FRANCESCO BURZOTTA@BURZOTTA_F·
#proglide and #manta allow safely seal #TAVR access entry site so effectively that surgical access looks today unacceptable in the majority of pts. Yet, vascular complications continue to occur so that improvement in anatomy-based device selection is deserved. #TAVI
Claudio Montalto@MdMontalto

🔥 Just published in @ehjopen @escardio In 9259 patients undergoing TAVR: 🔸MANTA ⬇️ bleedings and vascular complications 🔸ProGlide ⬇️ vascular complications in RCT/PM trials 🔸ProStar performed poorly compared to MANTA and ProGlide 🔖 Read here! doi.org/10.1093/ehjope…

English
0
4
10
0
Philipp Lauten, MD, FESC
Philipp Lauten, MD, FESC@PhilippLauten·
TAVI - statistics from HeartCenter @zentral_klinik 2021: 451 #TAVR cases: 0,8 % 30d mortality, 0,4 % stroke, 94% transfemoral access; 5% trans-axillary access: using 45% Edwards S3 , 44% Medtronic Evolut Platform, 11% Boston Acurate valves. Mean STS-Prom 3.9 %, mean age 80 years.
Erfurt, Germany 🇩🇪 English
4
3
45
0
mandeep singh
mandeep singh@mandeep_mayo·
Can you guess the procedure and its outcome?
mandeep singh tweet mediamandeep singh tweet media
English
46
77
348
0